Literature DB >> 6819649

Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter.

S C Fox, M Burgess-Wilson, S Heptinstall, J R Mitchell.   

Abstract

The Ultra-Flo 100 Whole Blood Platelet Counter has proved a useful tool for measuring platelet aggregation in whole blood, the extent of aggregation being deduced from the number of single platelets that remain. The technique has allowed us to show that platelets aggregate spontaneously in citrated blood and in heparinized blood but not in whole blood collected into EDTA. The aggregation occurs during storage but its rate is enhanced by stirring and it occurs more readily when the whole blood has been exposed to plastic rather than glass. It occurs much more readily in whole blood from some individuals than from others and the process may involve adenosine diphosphate (ADP). The rate of aggregation in whole blood is enhanced by several aggregating agents including collagen, ADP and sodium arachidonate which are more usually studied in platelet-rich plasma.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819649

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Inhibition of platelet aggregation by transdermal glyceryl trinitrate.

Authors:  R Andrews; J A May; J Vickers; S Heptinstall
Journal:  Br Heart J       Date:  1994-12

2.  Effects of combinations of 5-hydroxytryptamine receptor antagonists on 5-HT-induced human platelet aggregation.

Authors:  J Bevan; S Heptinstall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

3.  Studies on platelets before and after stroke in a patient with essential thrombocythaemia.

Authors:  S Heptinstall; S R Cockbill; M E Burgess-Wilson; E W Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

4.  Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.

Authors:  D M Gibb; D Dunger; M Levin; D Grant; P Jones; T M Barratt
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

5.  Physical and chemical effects of red cells in the shear-induced aggregation of human platelets.

Authors:  H L Goldsmith; D N Bell; S Braovac; A Steinberg; F McIntosh
Journal:  Biophys J       Date:  1995-10       Impact factor: 4.033

6.  Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis.

Authors:  N Brown; J A May; R G Wilcox; L M Allan; A M Wilson; P S Kiff; S Heptinstall
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

7.  Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.

Authors:  L Zhao; P Bath; S Heptinstall
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

8.  Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.

Authors:  M R Lawrence; F Broughton Pipkin
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

9.  The effect of a prostaglandin DP-receptor partial agonist (192C86) on platelet aggregation and the cardiovascular system in healthy volunteers.

Authors:  S J Gray; H Giles; J Posner
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

10.  Early markers of the renal complications of insulin dependent diabetes mellitus.

Authors:  D M Gibb; D Dunger; M Levin; V Shah; C Smith; T M Barratt
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.